All News

CHINOOK THERAPEUTICS ANNOUNCES LICENSE AGREEMENT WITH MOREHOUSE SCHOOL OF MEDICINE FOR DEVELOPMENT OF THERAPIES IN KIDNEY DISEASES DISPROPORTIONATELY AFFECTING AFRICAN AMERICANS AND UNDERSERVED COMMUNITIES

December 15, 2020 – Chinook Therapeutics Inc.

VANCOUVER, British Columbia and SEATTLE, Dec. 08, 2020 (GLOBE NEWSWIRE) — Chinook Therapeutics, Inc. (NASDAQ: KDNY), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, today announced that… Read More

Member News

CollPlant to Supply rhCollagen to STEMCELL Technologies for Use in a Broad Range of Cell Culture Applications

December 10, 2020 – STEMCELL Technologies Canada Inc.

REHOVOT, Israel and VANCOUVER, BC,– /PRNewswire/ – CollPlant (NASDAQ: CLGN), a regenerative medicine company, and STEMCELL Technologies, Canada’s largest privately-owned biotechnology company, which develops cell culture media, cell separation systems,… Read More

Member News

Neoleukin Therapeutics Announces Submission of Investigational New Drug Application for NL-201 De Novo Protein Immunotherapy Candidate for Cancer

December 10, 2020 – LSBC Comms

SEATTLE, Dec. 10, 2020 (GLOBE NEWSWIRE) — Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, today announced the submission of an Investigational… Read More

Member News

Qu Biologics Completes $8M Financing

December 9, 2020 – Qu Biologics Inc.

Vancouver, British Columbia – December 9, 2020 – Qu Biologics Inc., a private clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel platform of immunotherapies designed to restore… Read More

Member News

LifeLabs partners with Thrive Health to make it easier and safer for Canadians to confidently return to work during the COVID-19 pandemic

December 4, 2020 – Thrive Health

December 2, 2020 – LifeLabs and Vancouver-based Thrive Health are proud to announce a new partnership to empower organizations to better manage their COVID-19 testing and to help Canadians return… Read More

CHINOOK THERAPEUTICS ANNOUNCES LICENSE AGREEMENT WITH MOREHOUSE SCHOOL OF MEDICINE FOR DEVELOPMENT OF THERAPIES IN KIDNEY DISEASES DISPROPORTIONATELY AFFECTING AFRICAN AMERICANS AND UNDERSERVED COMMUNITIES

CollPlant to Supply rhCollagen to STEMCELL Technologies for Use in a Broad Range of Cell Culture Applications

Neoleukin Therapeutics Announces Submission of Investigational New Drug Application for NL-201 De Novo Protein Immunotherapy Candidate for Cancer

Qu Biologics Completes $8M Financing

LifeLabs partners with Thrive Health to make it easier and safer for Canadians to confidently return to work during the COVID-19 pandemic

Category:

Sector:

Archives:

CHINOOK THERAPEUTICS ANNOUNCES LICENSE AGREEMENT WITH MOREHOUSE SCHOOL OF MEDICINE FOR DEVELOPMENT OF THERAPIES IN KIDNEY DISEASES DISPROPORTIONATELY AFFECTING AFRICAN AMERICANS AND UNDERSERVED COMMUNITIES

CollPlant to Supply rhCollagen to STEMCELL Technologies for Use in a Broad Range of Cell Culture Applications

Neoleukin Therapeutics Announces Submission of Investigational New Drug Application for NL-201 De Novo Protein Immunotherapy Candidate for Cancer

Qu Biologics Completes $8M Financing

LifeLabs partners with Thrive Health to make it easier and safer for Canadians to confidently return to work during the COVID-19 pandemic

Newsletter Signup